Results 41 to 50 of about 28,971 (170)
Transcatheter Mitral Valve Replacement and Thrombosis: A Review
Frontiers in Cardiovascular Medicine, 2021 Mitral regurgitation is the most prevalent form of moderate or severe valve disease in developed countries. Surgery represents the standard of care for symptomatic patients with severe mitral regurgitation, but up to 50% of patients are denied surgery ...
Guido Ascione, Paolo Denti
doaj +1 more source
Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives [PDF]
Reviews in Cardiovascular Medicine, 2021 Transcatheter mitral valve repair with MitraClip has emerged as a possible therapeutic option for patients with severe mitral regurgitation (MR) with high risk for surgical valve repair. MitraClip intervention has demonstrated to improve haemodynamics
Alessandro Mandurino-Mirizzi +9 more
doaj +1 more source
Transcatheter mitral valve repair: a brief review [PDF]
EuroIntervention, 2015 Surgical treatment of mitral regurgitation has evolved from mitral valve replacement to repair, because the latter produces superior long-term outcomes. In addition, mitral valve repair can be achieved through minimally invasive approaches. The desire for less invasive approaches has driven the field of percutaneous mitral valve repair.
Barbanti, Marco +2 more
openaire +3 more sources
Association of Transcatheter Mitral Valve Repair Availability With Outcomes of Mitral Valve Surgery [PDF]
Journal of the American Heart Association, 2021 Background Transcatheter mitral valve repair (TMVr) is currently offered at selected centers that meet certain operator and institutional requirements. We sought to explore the hypothesis that the availability of TMVr is associated with improved outcomes of MV surgery. Methods and Results
Mohamad Alkhouli +7 more
openaire +3 more sources
REC: Interventional Cardiology (English Ed.), 2021 QUESTION: What is the current status of percutaneous coronary interventions to treat functional mitral regurgitation (MR)? ANSWER: To this date, transcatheter mitral valve repair therapies are backed by the highest scientific evidence.
Dabit Arzamendi
doaj +1 more source
The Future of Transcatheter Therapy for Mitral Valve Disease
Cardiovascular Innovations and Applications, 2016 The develop percutaneous treatments for mitral regurgitation (MR) have been based on established surgical procedures. Most are based in some way on mitral annuloplasty.
Ted Feldman, Mayra Guerrero
doaj +1 more source
JA Clinical Reports, 2022 Background Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is characterized by cardiac depression, respiratory failure, myopathy, and anesthesia for affected patients is challenging.
Atsuhiro Kitaura +3 more
semanticscholar +1 more source
First-in-Human Study of the Novel Transcatheter Mitral Valve Repair System for Mitral Regurgitation
JACC: Asia, 2022 Transcatheter mitral valve intervention treatment is a promising alternative therapy for patients with severe mitral regurgitation (MR). This is a multicenter, prospective, first-in-human study of transcatheter edge-to-edge repair (TEER) using a novel ...
Xian-Bao Liu +9 more
semanticscholar +1 more source
The Heart Surgery Forum, 2021 Purpose: To summarize comparative studies of MitraClip versus surgical repair in typical, real-world elderly patients with severe mitral regurgitation (MR) and analyze the safety and effectiveness of these therapeutic options. Methods: PubMed, Medline, Embase, and Cochrane Controlled Register of Trials (CENTRAL) were searched for comparative studies of
Haoyong Yuan +7 more
openaire +3 more sources
Heart Views, 2022 Mitral transcatheter edge-to-edge repair (MTEER) is the first transcatheter technique for mitral valve repair (MVR) in patients with severe mitral regurgitation (MR) who are considered at high risk for surgical intervention.
Khaled Al Khodari +3 more
doaj +1 more source